
Marxx Pharma Private Limited
About Marxx Pharma Private Limited
Data last updated:
Marxx Pharma Private Limited is a private limited company based in Hisar, Haryana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 December 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239HR2022PTC108475. Its GSTIN is 06AAQCM4602B1ZS (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rakhi Narang and Parveen Kumar Narang.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 177 Vikas Nagar Opp. Gugu Jambheshwar University, Hisar, Haryana, India – 125001.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.23 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹21.73 Lakh (net margin 1%) and EBITDA of ₹30.8 Lakh (EBITDA margin 1.5%).
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Marxx Pharma
Contact details
Marxx Pharma Private Limited's registered office is in Hisar, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 177 Vikas Nagar Opp. Gugu Jambheshwar University, Hisar, Haryana, India – 125001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Marxx Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Marxx Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Marxx Pharma Private Limited, buy the company report.
Financials of Marxx Pharma Private Limited
FY 2025 filings availableMarxx Pharma Private Limited reported revenue of ₹21.23 Cr (up 682% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 682% in the latest year. EBITDA rose 461% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹30.8 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹21.73 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.5% | |
| Net Profit Margin | 1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Marxx Pharma Private Limited, buy the company report.
Board of directors of Marxx Pharma Private Limited
Marxx Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakhi Narang | Director | 17 Dec 2022 | 3 Years 10 Months | Current |
| Parveen Kumar Narang | Director | 17 Dec 2022 | 3 Years 10 Months | Current |
Peer comparison
Marxx Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dexbio Pharma Private Limited | ₹21.29 Cr (FY 2025) | 17.0% | Roorkee, Uttarakhand, India | |||
| Dios Lifesciences Private Limited | ₹21.24 Cr (FY 2024) | 44.0% | New Delhi, Delhi, India | |||
| Elfin Drugs Private Limited | ₹21.23 Cr (FY 2024) | 15.0% | Mohali, Punjab, India | |||
| Marxx Pharma Private Limitedthis company | ₹21.23 Cr (FY 2024) | ₹21.73 Lakh | 1% | 682.0% | Hisar, Haryana, India | |
| Ravi Pharmaceuticals Pvt Ltd | ₹21.23 Cr (FY 2024) | 15.0% | Khambhat, Gujarat, India | |||
| Glowsun India Labs Private Limited | ₹21.2 Cr (FY 2024) | 11.0% | Dehradun, Uttarakhand, India | |||
| Ethicare Pharmaceuticals Private Limited | ₹21.2 Cr (FY 2025) | 94.0% | Vadodara, Gujarat, India | |||
| Tetradrip Pharma Private Limited | ₹21.18 Cr (FY 2024) | 91.0% | Burdwan, West Bengal, India |
To see the full peer comparison of Marxx Pharma Private Limited, buy the company report.
Auditor
Marxx Pharma Private Limited is audited by RRR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RRR & CO. | FY 2023 | 500260 |
Shareholding
The shareholding of Marxx Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Marxx Pharma Private Limited, buy the company report.
Legal cases
Marxx Pharma Private Limited has 1 court case on record: 1 filed by Marxx Pharma. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr. | Pending |
To see the full case history of Marxx Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Marxx Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Marxx Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAQCM4602B1ZS | Haryana | Active | 30 Jan 2023 |
To see the full GST registrations and return filing status of Marxx Pharma Private Limited, buy the company report.
Recent activity
Marxx Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Parveen Kumar Narang was appointed as Director on 17 Dec 2022.
Frequently asked questions
Marxx Pharma is an active private limited company based in Hisar, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 December 2022 (4+ years old) and is registered under CIN U24239HR2022PTC108475.
Marxx Pharma has 2 current directors:
- Rakhi Narang - Director
- Parveen Kumar Narang - Director
The latest financial statements of Marxx Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Marxx Pharma is 06AAQCM4602B1ZS, registered in Haryana.
The CIN (Corporate Identification Number) of Marxx Pharma is U24239HR2022PTC108475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marxx Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Marxx Pharma was incorporated on 17 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Marxx Pharma by revenue are Dexbio Pharma Private Limited, Dios Lifesciences Private Limited, Elfin Drugs Private Limited, Ravi Pharmaceuticals Pvt Ltd, Glowsun India Labs Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Parveen Kumar Narang was appointed as Director on 17 Dec 2022. Rakhi Narang was appointed as Director on 17 Dec 2022.
Yes, Marxx Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Marxx Pharma is at Plot No 177 Vikas Nagar Opp. Gugu Jambheshwar University, Hisar, Haryana, India – 125001.

